Investing in early research has led to 11 MS therapies in the last 5 years, including the first therapies for progressive MS and pediatric MS.
Co-founded and committed $25 million to the International Progressive MS Alliance, an unprecedented global collaboration of 20 MS organizations to accelerate treatments for progressive MS.
Garnered FDA support for a blood test that can signal MS progression in clinical trials and could someday be used to indicate and stop MS before symptoms start.